Trials that use: Mixed-effects model
New to this method? Read the tutorial →
279 results
- GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers’ Exposure to Retail Environments: Complete Statistical AnalysisIndependent statistical analysis of GeoScan and Remote Geo Smoking Study: Neural and Behavioral Correlates of Smokers' Exposure to Retail Environments: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Girls on the Move Intervention to Increase Physical Activity Among Middle School Girls: Complete Statistical AnalysisIndependent statistical analysis of Girls on the Move Intervention to Increase Physical Activity Among Middle School Girls: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- GLEAMIndependent statistical analysis of A Trial to Evaluate the Efficacy, Durability, and Safety of KSI-301 Compared to Aflibercept in Participants With Diabetic Macular Edema (DME): primary endpoint results, effect estimate with confidence…
- GLIDERIndependent statistical analysis of A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Primary Sjögren's Syndrome (pSS): primary endpoint results, effect estimate…
- GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: Complete Statistical AnalysisIndependent statistical analysis of GSK573719 Dose Ranging Study in Chronic Obstructive Pulmonary Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00950807).
- GUIDEDIndependent statistical analysis of Genomics Used to Improve DEpression Decisions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02109939).
- HALT PKD AIndependent statistical analysis of HALT Progression of Polycystic Kidney Disease Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00283686).
- HARMONIZE GLIndependent statistical analysis of A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Health Literacy Interventions to Overcome Disparities in CRC Screening: Complete Statistical AnalysisIndependent statistical analysis of Health Literacy Interventions to Overcome Disparities in CRC Screening: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02360605).
- Hestia2Independent statistical analysis of A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell Disease: primary endpoint results, effect estimate with…
- IDENTITY-2Independent statistical analysis of Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- IGNAZIndependent statistical analysis of Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- IMAGINE 2Independent statistical analysis of A Study in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01435616).
- INVIGORATEIndependent statistical analysis of Exacerbation Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00845728).
- IOPAIndependent statistical analysis of A Study for Patients With Diabetes Mellitus (IOPA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00420095).
- iPOP-UPIndependent statistical analysis of Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05627011).
- IRISComplete statistical analysis of the IRIS trial of pioglitazone versus placebo after stroke or myocardial infarction, including trial design, time-to-event endpoints, Cox modeling, mixed-effects analysis, multiplicity, interim analysis, results, and statistical interpretation.
- KOMETIndependent statistical analysis of Efficacy and Safety of Selumetinib in Adults With NF1 Who Have Symptomatic, Inoperable Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- LIBERTY ASTHMA QUESTAn independent statistical analysis of the phase 3 LIBERTY ASTHMA QUEST trial of dupilumab 200 mg and 300 mg every two weeks versus matched placebo in persistent asthma, covering negative binomial rate…
- LIDSIndependent statistical analysis of A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- LOUiSSeIndependent statistical analysis of A Phase 2 Study to Evaluate the Safety and Efficacy of LOU064 in Patients With Moderate to Severe Sjögren's Syndrome: primary endpoint results, effect estimate with confidence interval,…
- LUX-Lung 7Independent statistical analysis of LUX-Lung 7, the randomized phase 2 trial comparing afatinib with gefitinib in first-line EGFR mutation-positive lung adenocarcinoma, including survival, response, quality-of-life, and safety analyses.
- MA.17Independent statistical analysis of MA.17, a randomized phase 3 trial evaluating letrozole versus placebo in women with breast cancer who had received 5 years of aromatase inhibitor therapy, including disease-free survival, overall…
- MERLINIndependent statistical analysis of A Trial of Bardoxolone Methyl in Patients With CKD at Risk of Rapid Progression (MERLIN): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MONARCH 3Independent statistical analysis of the phase 3 MONARCH 3 trial of abemaciclib plus a nonsteroidal aromatase inhibitor in postmenopausal women with breast cancer, including progression-free survival, response, health-status outcomes, methodology, safety, and…
- MORPHEOIndependent statistical analysis of A Phase 4, Randomized, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study of the Effect of Dupilumab on Sleep Disturbance in Patients With Uncontrolled Persistent Asthma: primary endpoint results, effect estimate…
- NAVIGATORIndependent statistical analysis of the phase 3 NAVIGATOR trial (NCT03347279) of tezepelumab 210mg Q4W versus placebo in severe uncontrolled asthma: negative binomial exacerbation rate ratios, mixed-model secondary endpoints, safety and interpretation.
- NEXUSIndependent statistical analysis of Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- OASIS(CM)Independent statistical analysis of Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- OlympiADIndependent statistical analysis of the OlympiAD phase 3 trial of olaparib monotherapy versus physician's choice chemotherapy in metastatic breast cancer patients with germline BRCA1/2 mutations.
- ORIGINALComplete statistical analysis of the ORIGINAL phase 3 trial comparing tenecteplase with alteplase in Chinese patients with stroke, including trial design, non-inferiority methodology, efficacy, safety, and interpretation.
- PALOMA-2Independent statistical analysis of PALOMA-2 (NCT01740427), a randomized phase 3 trial of palbociclib plus letrozole versus placebo plus letrozole in postmenopausal women with ER+/HER2- advanced breast cancer.
- PALOMA-4Independent statistical analysis of PALOMA-4, a randomized phase 3 trial comparing palbociclib plus letrozole with placebo plus letrozole in Asian postmenopausal women with ER+/HER2- advanced breast cancer.
- PARALLAXComplete statistical analysis of the PARALLAX phase 3 trial of sacubitril/valsartan versus individualized medical therapy in patients with heart failure with preserved ejection fraction, including endpoint definitions, mixed-effects and logistic regression methods,…
- PEOPLEComplete statistical analysis of the PEOPLE phase 3 trial of post-exposure prophylaxis for leprosy in the Comoros and Madagascar, including trial design, incidence rate ratios, mixed-effects methodology, confidence intervals, and interpretation.
- PREVAIL-PIndependent statistical analysis of Exercise After Clinically Significant Weight Loss: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03685123).
- PROFILE 1014Independent statistical analysis of PROFILE 1014, evaluating crizotinib versus pemetrexed plus cisplatin or carboplatin in ALK-positive non-squamous lung cancer, with detailed interpretation of progression-free survival, overall survival, response, patient-reported outcomes, and statistical…
- PROLONG-ANG3Independent statistical analysis of A Study of LY3561774 in Participants With Mixed Dyslipidemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05256654).
- PRONTO-PumpIndependent statistical analysis of A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes: primary endpoint results, effect estimate with…
- PRONTO-T1DA detailed statistical analysis of the randomized phase 3 PRONTO-T1D trial of LY900014 in participants with type 1 diabetes, including HbA1c, postprandial glucose, non-inferiority, ANCOVA, mixed-effects modeling, and safety.
- PRONTO-T2DIndependent statistical analysis of A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- RA-MOBILITYComplete statistical analysis of RA-MOBILITY, evaluating sarilumab on top of methotrexate in rheumatoid arthritis, including ACR20 response, HAQ-DI, structural damage, multiplicity, and registry-reported statistical results.
- RALLYIndependent statistical analysis of A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- RED-HFIndependent statistical analysis of the RED-HF phase 3 trial of darbepoetin alfa in heart failure, including trial design, time-to-event endpoints, hazard ratios, KCCQ analyses, safety, methodology, and statistical interpretation.
- RELAX-AHF-EUComplete statistical analysis of RELAX-AHF-EU, a randomized phase 3 trial evaluating serelaxin plus standard of care versus standard of care in patients with acute heart failure, including time-to-event, categorical, continuous, and longitudinal…
- RELEASE MSS5Independent statistical analysis of Evaluation of the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Participants With Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- RESTORE-MEIndependent statistical analysis of Effects of a Resistance Training Program in Older Women With Sarcopenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RHINEIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SADHART-CHFIndependent statistical analysis of Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Skylight 2Independent statistical analysis of A Study to Find Out if Fezolinetant Helps Reduce Moderate to Severe Hot Flashes in Women Going Through Menopause - 2: primary endpoint results, effect estimate with confidence…